Aprea Therapeutics, Inc. 10-Q filing
Filed 2026-05-13 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001104659-26-059743
- Form type
- 10-Q
- CIK
- 0001781983
- Primary document
- https://www.sec.gov/Archives/edgar/data/1781983/000110465926059743/apre-20260331x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Aprea Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-3.4M | - | - |
| Net Income | $-3.3M | - | - |
| Eps Basic | -0.22 | - | - |
| Eps Diluted | -0.22 | - | - |
| Cash And Equivalents | $46.5M | - | - |
| Total Assets | $47.6M | - | - |
| Shareholders Equity | $41.6M | - | - |
| Operating Cash Flow | $-2.8M | - | - |